172 related articles for article (PubMed ID: 32567756)
1. Intralipid treatment for women with reproductive failures.
Coulam CB
Am J Reprod Immunol; 2021 Apr; 85(4):e13290. PubMed ID: 32567756
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy to improve pregnancy outcome in women with abnormal natural killer cell levels/activity and recurrent miscarriage or implantation failure: A systematic review and meta-analysis.
Woon EV; Day A; Bracewell-Milnes T; Male V; Johnson M
J Reprod Immunol; 2020 Nov; 142():103189. PubMed ID: 32889304
[TBL] [Abstract][Full Text] [Related]
3. Intravenous intralipid therapy is not beneficial in having a live delivery in women aged 40-42 years with a previous history of miscarriage or failure to conceive despite embryo transfer undergoing in vitro fertilization-embryo transfer.
Check JH; Check DL
Clin Exp Obstet Gynecol; 2016; 43(1):14-5. PubMed ID: 27048011
[TBL] [Abstract][Full Text] [Related]
4. Intralipid® may represent a new hope for patients with reproductive failures and simultaneously an over-immune endometrial activation.
Lédée N; Vasseur C; Petitbarat M; Chevrier L; Vezmar K; Dray G; Chenière S; Lobersztajn A; Vitoux D; Cassuto GN; Chaouat G
J Reprod Immunol; 2018 Nov; 130():18-22. PubMed ID: 30286362
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and potential mechanisms of intralipid in treating unexplained recurrent spontaneous abortion.
Meng L; Lin J; Chen L; Wang Z; Liu M; Liu Y; Chen X; Zhu L; Chen H; Zhang J
Arch Gynecol Obstet; 2016 Jul; 294(1):29-39. PubMed ID: 26671484
[TBL] [Abstract][Full Text] [Related]
6. Intralipid supplementation in women with recurrent spontaneous abortion and elevated levels of natural killer cells.
Dakhly DM; Bayoumi YA; Sharkawy M; Gad Allah SH; Hassan MA; Gouda HM; Hashem AT; Hatem DL; Ahmed MF; El-Khayat W
Int J Gynaecol Obstet; 2016 Dec; 135(3):324-327. PubMed ID: 27614789
[TBL] [Abstract][Full Text] [Related]
7. Intralipid therapy and adverse reproductive outcome: is there any evidence?
Kumar P; Marron K; Harrity C
Reprod Fertil; 2021 Jul; 2(3):173-186. PubMed ID: 35118388
[TBL] [Abstract][Full Text] [Related]
8. Duration of intralipid's suppressive effect on NK cell's functional activity.
Roussev RG; Acacio B; Ng SC; Coulam CB
Am J Reprod Immunol; 2008 Sep; 60(3):258-63. PubMed ID: 18782287
[TBL] [Abstract][Full Text] [Related]
9. The effect of administration of intravenous intralipid on pregnancy outcomes in women with implantation failure after IVF/ICSI with non-donor oocytes: A randomised controlled trial.
Singh N; Davis AA; Kumar S; Kriplani A
Eur J Obstet Gynecol Reprod Biol; 2019 Sep; 240():45-51. PubMed ID: 31228675
[TBL] [Abstract][Full Text] [Related]
10. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy.
Roussev RG; Dons'koi BV; Stamatkin C; Ramu S; Chernyshov VP; Coulam CB; Barnea ER
Reprod Biomed Online; 2013 Jan; 26(1):79-87. PubMed ID: 23186554
[TBL] [Abstract][Full Text] [Related]
11. Does immunotherapy for treatment of reproductive failure enhance live births?
Coulam CB; Acacio B
Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
[TBL] [Abstract][Full Text] [Related]
12. Intralipid therapy for unexplained recurrent miscarriage and implantation failure: Case-series and literature review.
Plaçais L; Kolanska K; Kraiem YB; Cohen J; Suner L; Bornes M; Sedille L; Rosefort A; D'Argent EM; Selleret L; Abisror N; Johanet C; Buffet NC; Darai E; Antoine JM; Fain O; Kayem G; Mekinian A
Eur J Obstet Gynecol Reprod Biol; 2020 Sep; 252():100-104. PubMed ID: 32592916
[TBL] [Abstract][Full Text] [Related]
13. Preimplantation genetic testing for aneuploidy: a comparison of live birth rates in patients with recurrent pregnancy loss due to embryonic aneuploidy or recurrent implantation failure.
Sato T; Sugiura-Ogasawara M; Ozawa F; Yamamoto T; Kato T; Kurahashi H; Kuroda T; Aoyama N; Kato K; Kobayashi R; Fukuda A; Utsunomiya T; Kuwahara A; Saito H; Takeshita T; Irahara M
Hum Reprod; 2019 Dec; 34(12):2340-2348. PubMed ID: 31811307
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the Utility of Intralipid Infusion to Improve Live Birth Rates in Patients with Recurrent Pregnancy Loss or Recurrent Implantation Failure.
Martini AE; Jasulaitis S; Fogg LF; Uhler ML; Hirshfeld-Cytron JE
J Hum Reprod Sci; 2018; 11(3):261-268. PubMed ID: 30568356
[TBL] [Abstract][Full Text] [Related]
15. Clinical applications of intravenous lipid emulsion therapy.
Muller SH; Diaz JH; Kaye AD
J Anesth; 2015 Dec; 29(6):920-6. PubMed ID: 26049929
[TBL] [Abstract][Full Text] [Related]
16. Use of Intralipid® in managing refractory hypotension following epidural blockade.
Tsui BC; Cheung SS; Ziwenga O; Gragasin FS
Can J Anaesth; 2015 May; 62(5):548-9. PubMed ID: 25420471
[No Abstract] [Full Text] [Related]
17. Lipid emulsion therapy in women with recurrent pregnancy loss and repeated implantation failure: The role of abnormal natural killer cell activity.
Canella PRBC; Barini R; Carvalho PO; Razolli DS
J Cell Mol Med; 2021 Mar; 25(5):2290-2296. PubMed ID: 33544456
[TBL] [Abstract][Full Text] [Related]
18. Expression of natural cytotoxicity receptors and cytokine production on endometrial natural killer cells in women with recurrent pregnancy loss or implantation failure, and the expression of natural cytotoxicity receptors on peripheral blood natural killer cells in pregnant women with a history of recurrent pregnancy loss.
Fukui A; Funamizu A; Fukuhara R; Shibahara H
J Obstet Gynaecol Res; 2017 Nov; 43(11):1678-1686. PubMed ID: 28815854
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell functional activity suppression by intravenous immunoglobulin, intralipid and soluble human leukocyte antigen-G.
Roussev RG; Ng SC; Coulam CB
Am J Reprod Immunol; 2007 Apr; 57(4):262-9. PubMed ID: 17362387
[TBL] [Abstract][Full Text] [Related]
20. Ineffectiveness of intralipid infusion for central nervous toxicity following ultrasound-guided sciatic nerve block with lidocaine-ropivacaine solution: interaction between carbamazepine, local anaesthetic and intralipid?
Aveline C; Cognet F; Bonnet F
Eur J Anaesthesiol; 2010 Dec; 27(12):1070-2. PubMed ID: 20671556
[No Abstract] [Full Text] [Related]
[Next] [New Search]
